HIV, Hetero and Gilead Sciences
Hetero enters into agreement with Gilead to manufacture and distribute multi drug-resistant HIV
Lenacapavir was approved for use in HIV-positive adults with multi-drug resistance by the European Union in August 2022 and received U.S. FDA approval in December 2022.
Hetero Inks Voluntary Licensing Pact with Gilead for HIV Drug Lenacapavir
Hetero has partnered with Gilead Sciences to manufacture and distribute the HIV drug lenacapavir in 120 low- and middle-income countries, aiming to improve access to treatment and prevention. Lenacapavir,
Hetero & Gilead Partner for HIV Drug Lenacapavir Access
Hetero and Gilead have partnered to expand access to lenacapavir, a groundbreaking HIV treatment, in 120 low- and middle-income countries. This partnership aims to improve treatment options and expand HIV prevention through PrEP.
Dr Reddy's, Hetero sign voluntary licenses with Gilead for HIV drug
Gilead Sciences first launched lenacapavir under the brand name Sunlenca in the United States and European markets in 2022. It is a first-in-class HIV-1 capsid inhibitor
Indian pharma firms ink deal with U.S. drug maker Gilead to make, market generic HIV drug lenacapavir
Dr. Reddy's, Hetero, and Mylan partner with Gilead Sciences to manufacture generic lenacapavir for HIV prevention globally.
Gilead Licenses Long-Acting HIV Prevention Drug to Generics Firms
Gilead Sciences Inc. said it is licensing its twice-yearly experimental HIV prevention drug lenacapavir to six generics makers after coming under fire from HIV advocates who argued the company was prioritizing profit over patients.
Gilead Licenses HIV-prevention Drug To Generic Drugmakers
US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income countries.
Pan-D, Paracetamol, vitamin tablets Shelcal among 53 top-selling drugs fail quality test by Indian regulator
The drugs found to have failed quality tests include Paracetamol IP 500 mg, Pan-D (an antiacid), Vitamin B complex and ...
Paracetamol, Pan-D amongst 50 popular drugs that fail quality tests in India: What you need to know
India's drug regulator has identified 53 drugs, including supplements and medications for diabetes and high blood pressure, ...
Onlymyhealth7d
Major Pharma Firms In India Face Scrutiny For Quality Lapses: 53 Drugs Under Investigation
Major pharma firms in India face scrutiny as 53 drugs including paracetamol fail quality tests raising safety concerns ...
Pharmabiz1d
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir
Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based ...
India's CDSCO flags quality issues with over 50 widely used drugs
India's drug regulator has found more than 50 drugs, including some batches of widely used antacids and paracetamol, to be ...
Paracetamol among 53 drugs to fail quality control: What safe alternatives can you turn to?
It might be time to discard your trusty strip of Paracetamol. The hot-favourite drug option for fever control has alarmingly ...